Leal Santos Sofia, Chen Briana K, Pereira Guilherme R, Pham Vananh, Denny Christine A
Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, United States.
Division of Systems Neuroscience, Research Foundation for Mental Hygiene, Inc. (RFMH)/New York State Psychiatric Institute (NYSPI), New York, NY, United States.
Front Behav Neurosci. 2022 Jul 7;16:919831. doi: 10.3389/fnbeh.2022.919831. eCollection 2022.
Altered fear learning is a strong behavioral component of anxiety disorders such as post-traumatic stress disorder (PTSD). Recent efforts have attempted to combine exposure therapies with drugs that target fear memory retrieval and memory reconsolidation, in order to improve treatment efficacy. The noradrenergic (NA) signaling system is of particular interest, due to its role in regulating the stress response and its involvement in fear and learning processes. Importantly, propranolol (P), a non-selective β-adrenergic antagonist, has shown the potential in decreasing exaggerated fear in both humans and animal models. In a previous study, we utilized an activity-dependent tagging murine model to determine the neural mechanisms by which propranolol attenuates learned fear. We found that propranolol acutely decreased memory trace reactivation specifically in the dorsal dentate gyrus (dDG), but not in CA3 or CA1. Here, we extended our previous study by investigating whether propranolol additionally altered activity in the hilus, a polymorphic layer that consists of neurons, mossy cells, and GABAergic interneurons. We found that propranolol acutely reduced overall hilar activity in both the dorsal and ventral hilus. Moreover, we report that propranolol significantly altered the activity of parvalbumin (PV) cells in the ventral (vDG), but not dorsal DG (dDG). Together, these results suggest that a β-adrenergic blockade may affect the activity of excitatory and inhibitory cell types in the hilar layer of the DG, and that these alterations may contribute to manipulating fear memory traces.
恐惧学习改变是创伤后应激障碍(PTSD)等焦虑症的一个重要行为组成部分。最近的研究尝试将暴露疗法与针对恐惧记忆提取和记忆再巩固的药物相结合,以提高治疗效果。去甲肾上腺素能(NA)信号系统特别受关注,因为它在调节应激反应以及参与恐惧和学习过程中发挥作用。重要的是,普萘洛尔(P),一种非选择性β-肾上腺素能拮抗剂,已显示出在减少人类和动物模型中过度恐惧方面的潜力。在之前的一项研究中,我们利用一种活动依赖性标记小鼠模型来确定普萘洛尔减轻习得性恐惧的神经机制。我们发现普萘洛尔能急性降低背侧齿状回(dDG)而非CA3或CA1中的记忆痕迹再激活。在此,我们通过研究普萘洛尔是否还会改变齿状回门区(一个由神经元、苔藓细胞和GABA能中间神经元组成的多形层)的活动来扩展我们之前的研究。我们发现普萘洛尔能急性降低背侧和腹侧齿状回门区的整体活动。此外,我们报告普萘洛尔显著改变了腹侧齿状回(vDG)而非背侧齿状回(dDG)中小白蛋白(PV)细胞的活动。总之,这些结果表明β-肾上腺素能阻断可能会影响齿状回门区兴奋性和抑制性细胞类型的活动,并且这些改变可能有助于操纵恐惧记忆痕迹。